Drug Type Small molecule drug |
Synonyms Inhaled fosfomycin/tobramycin, Tobramycin/fosfomycin inhalation, CORUS 1040 + [2] |
Target |
Action inhibitors |
Mechanism 30S subunit inhibitors(30S ribosomal subunit inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC3H7NaO4P |
InChIKeyBLLKJRKIOJQXCC-LJUKVTEVSA-N |
CAS Registry26016-99-9 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | Fosfomycin/Tobramycin | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Cystic Fibrosis | Phase 2 | United States | 01 Nov 2008 |





